Cargando…

Quality of life in patients with transcatheter aortic valve implantation: an analysis from the INTERVENT project

BACKGROUND: Transcatheter aortic valve implantation (TAVI) is a standard treatment for patients with aortic valve stenosis due to its very low mortality and complication rates. However, survival and physical integrity are not the only important factors. Quality of life (QoL) improvement is a crucial...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamm, Alexander R., Jobst, Marina L., Geyer, Martin, Hahad, Omar, Buderus, Victoria, Schmidt, Alexander, Prochaska, Jürgen H., Wild, Philipp S., Treede, Hendrik, Münzel, Thomas, von Bardeleben, Ralph Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10330696/
https://www.ncbi.nlm.nih.gov/pubmed/37435055
http://dx.doi.org/10.3389/fcvm.2023.1181771
_version_ 1785070141693755392
author Tamm, Alexander R.
Jobst, Marina L.
Geyer, Martin
Hahad, Omar
Buderus, Victoria
Schmidt, Alexander
Prochaska, Jürgen H.
Wild, Philipp S.
Treede, Hendrik
Münzel, Thomas
von Bardeleben, Ralph Stephan
author_facet Tamm, Alexander R.
Jobst, Marina L.
Geyer, Martin
Hahad, Omar
Buderus, Victoria
Schmidt, Alexander
Prochaska, Jürgen H.
Wild, Philipp S.
Treede, Hendrik
Münzel, Thomas
von Bardeleben, Ralph Stephan
author_sort Tamm, Alexander R.
collection PubMed
description BACKGROUND: Transcatheter aortic valve implantation (TAVI) is a standard treatment for patients with aortic valve stenosis due to its very low mortality and complication rates. However, survival and physical integrity are not the only important factors. Quality of life (QoL) improvement is a crucial part in the evaluation of therapy success. METHODS: Patients with TAVI were questioned about their QoL before, one month and one year after the intervention as part of the INTERVENT registry trial at Mainz University Medical Center. Three different questionnaires were included in the data collection (Katz ADL, EQ-5D-5l, PHQ-D). RESULTS: We included 285 TAVI patients in the analysis (mean age 79.8 years, 59.4% male, mean EuroSCORE II 3.8%). 30-day mortality was 3.6%, complications of any kind occurred in 18.9% of the patients. Main finding was a significant increase in the general state of health measured on the visual analog scale by an average of 4.53 (± 23.58) points (BL to 1-month follow-up, p = 0.009) and by 5.19 (± 23.64) points (BL to 12-month follow-up, p = 0.016). There was also an improvement of depression symptoms, which was reflected in a decrease in the total value of the PHQ-D by 1.67 (± 4.75) points (BL to 12-month follow-up, p = 0.001). The evaluation of the EQ-5D-5l showed a significant improvement in mobility after one month (M = −0.41 (± 1.31), p < 0.001. Regarding the independence of the patients, no significant difference could be found. Apart from that, patients with risk factors, comorbidities or complications also benefited from the intervention despite their poor starting position. CONCLUSION: We could show an early benefit of QoL in TAVI patients with significant improvement in the subjective state of health and a decrease in symptoms of depression. These findings were consistent over 1 year of follow up.
format Online
Article
Text
id pubmed-10330696
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103306962023-07-11 Quality of life in patients with transcatheter aortic valve implantation: an analysis from the INTERVENT project Tamm, Alexander R. Jobst, Marina L. Geyer, Martin Hahad, Omar Buderus, Victoria Schmidt, Alexander Prochaska, Jürgen H. Wild, Philipp S. Treede, Hendrik Münzel, Thomas von Bardeleben, Ralph Stephan Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: Transcatheter aortic valve implantation (TAVI) is a standard treatment for patients with aortic valve stenosis due to its very low mortality and complication rates. However, survival and physical integrity are not the only important factors. Quality of life (QoL) improvement is a crucial part in the evaluation of therapy success. METHODS: Patients with TAVI were questioned about their QoL before, one month and one year after the intervention as part of the INTERVENT registry trial at Mainz University Medical Center. Three different questionnaires were included in the data collection (Katz ADL, EQ-5D-5l, PHQ-D). RESULTS: We included 285 TAVI patients in the analysis (mean age 79.8 years, 59.4% male, mean EuroSCORE II 3.8%). 30-day mortality was 3.6%, complications of any kind occurred in 18.9% of the patients. Main finding was a significant increase in the general state of health measured on the visual analog scale by an average of 4.53 (± 23.58) points (BL to 1-month follow-up, p = 0.009) and by 5.19 (± 23.64) points (BL to 12-month follow-up, p = 0.016). There was also an improvement of depression symptoms, which was reflected in a decrease in the total value of the PHQ-D by 1.67 (± 4.75) points (BL to 12-month follow-up, p = 0.001). The evaluation of the EQ-5D-5l showed a significant improvement in mobility after one month (M = −0.41 (± 1.31), p < 0.001. Regarding the independence of the patients, no significant difference could be found. Apart from that, patients with risk factors, comorbidities or complications also benefited from the intervention despite their poor starting position. CONCLUSION: We could show an early benefit of QoL in TAVI patients with significant improvement in the subjective state of health and a decrease in symptoms of depression. These findings were consistent over 1 year of follow up. Frontiers Media S.A. 2023-06-26 /pmc/articles/PMC10330696/ /pubmed/37435055 http://dx.doi.org/10.3389/fcvm.2023.1181771 Text en © 2023 Tamm, Jobst, Geyer, Hahad, Buderus, Schmidt, Prochaska, Wild, Treede, Münzel and von Bardeleben. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Tamm, Alexander R.
Jobst, Marina L.
Geyer, Martin
Hahad, Omar
Buderus, Victoria
Schmidt, Alexander
Prochaska, Jürgen H.
Wild, Philipp S.
Treede, Hendrik
Münzel, Thomas
von Bardeleben, Ralph Stephan
Quality of life in patients with transcatheter aortic valve implantation: an analysis from the INTERVENT project
title Quality of life in patients with transcatheter aortic valve implantation: an analysis from the INTERVENT project
title_full Quality of life in patients with transcatheter aortic valve implantation: an analysis from the INTERVENT project
title_fullStr Quality of life in patients with transcatheter aortic valve implantation: an analysis from the INTERVENT project
title_full_unstemmed Quality of life in patients with transcatheter aortic valve implantation: an analysis from the INTERVENT project
title_short Quality of life in patients with transcatheter aortic valve implantation: an analysis from the INTERVENT project
title_sort quality of life in patients with transcatheter aortic valve implantation: an analysis from the intervent project
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10330696/
https://www.ncbi.nlm.nih.gov/pubmed/37435055
http://dx.doi.org/10.3389/fcvm.2023.1181771
work_keys_str_mv AT tammalexanderr qualityoflifeinpatientswithtranscatheteraorticvalveimplantationananalysisfromtheinterventproject
AT jobstmarinal qualityoflifeinpatientswithtranscatheteraorticvalveimplantationananalysisfromtheinterventproject
AT geyermartin qualityoflifeinpatientswithtranscatheteraorticvalveimplantationananalysisfromtheinterventproject
AT hahadomar qualityoflifeinpatientswithtranscatheteraorticvalveimplantationananalysisfromtheinterventproject
AT buderusvictoria qualityoflifeinpatientswithtranscatheteraorticvalveimplantationananalysisfromtheinterventproject
AT schmidtalexander qualityoflifeinpatientswithtranscatheteraorticvalveimplantationananalysisfromtheinterventproject
AT prochaskajurgenh qualityoflifeinpatientswithtranscatheteraorticvalveimplantationananalysisfromtheinterventproject
AT wildphilipps qualityoflifeinpatientswithtranscatheteraorticvalveimplantationananalysisfromtheinterventproject
AT treedehendrik qualityoflifeinpatientswithtranscatheteraorticvalveimplantationananalysisfromtheinterventproject
AT munzelthomas qualityoflifeinpatientswithtranscatheteraorticvalveimplantationananalysisfromtheinterventproject
AT vonbardelebenralphstephan qualityoflifeinpatientswithtranscatheteraorticvalveimplantationananalysisfromtheinterventproject